Impedimed
- Short interest
- <0.01%
- −0.33 pp 30d
- as of 2 July 2026
- Reported shorts
- 99.8K
- Shares on issue
- 3.660B
Impedimed (IPD) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Quarterly Activities Report and Appendix 4C - Sep-2026 Qtr
other announcement
Change of Director's Interest Notice - Mr Andrew Grant
director_dealing announcement
Application for quotation of securities - IPD
other announcement
Change of Director's Interest Notice - Ms Fiona Bones
director_dealing announcement
Cancer survivorship pioneer appointed to scale SOZO
other announcement
Notification of Q1 FY27 Quarterly Results Investor Webinar
other announcement
Change of Director's Interest Notice - Ms Janelle Delaney
director_dealing announcement
Annual General Meeting - Online Meeting Guide
other announcement
Notice of Annual General Meeting & Voting Form
other announcement
Application for quotation of securities - IPD
other announcement
Notice of Initial Substantial Holder
other announcement
Change of Director's Interest Notice - Mr Erik Anderson
director_dealing announcement
Date of 2026 Annual General Meeting
other announcement
ImpediMed (ASX:IPD): Why Its SOZO Platform and Growth Strategy Remain in Focus? - Kalkine
ImpediMed (ASX:IPD): Why Its SOZO Platform and Growth Strategy Remain in Focus? Kalkine
ImpediMed Limited (ASX:IPD) Just Reported, And Analysts Assigned A AU$0.021 Price Target - simplywall.st
ImpediMed Limited (ASX:IPD) Just Reported, And Analysts Assigned A AU$0.021 Price Target simplywall.st
ImpediMed (ASX:IPD) FDA Clearance Expands SOZO Opportunity as Commercial Execution Remains Key - Kalkine
ImpediMed (ASX:IPD) FDA Clearance Expands SOZO Opportunity as Commercial Execution Remains Key Kalkine
FDA Clearance for Sarcopenia Risk Assessment Received
other announcement
IPD Group Shares Break Higher, Fundamentals Support The Move - thebull.com.au
IPD Group Shares Break Higher, Fundamentals Support The Move thebull.com.au


IPD Group reports record profits and dividends in FY26
IPD Group lifted FY26 revenue, profit and dividends above guidance. The post IPD Group reports record profits and dividends in FY26 appeared first on The Motley Fool Australia.
Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr
other announcement
Notification of Q4 FY26 Quarterly Results Investor Webinar
other announcement
ImpediMed Limited Announces Expiry of 2.6 Million Unquoted Options Due to Unmet Conditions
ImpediMed Limited (ASX: IPD) has informed the ASX that 2,635,000 unquoted options (IPDAAB) expired on 30 June 2026 following the lapse of conditional rights. These options, which had varying exercise prices and expiry dates, ceased due to failure to meet the attached conditions. Despite this lapse, the company’s issued capital structure remains largely unchanged, with ordinary shares and other option classes continuing to trade and remain outstanding. Key Highlights ImpediMed Limited (IPD) ...
ImpediMed (ASX:IPD) Posts A$7.5M Revenue—Could This Medtech Stock Be Approaching Inflection Point? - Kalkine
ImpediMed (ASX:IPD) Posts A$7.5M Revenue—Could This Medtech Stock Be Approaching Inflection Point? Kalkine
Change of Director's Interest Notice - Mr Erik Anderson
director_dealing announcement
Change of Director's Interest Notice - Ms Janelle Delaney
director_dealing announcement
ImpediMed (ASX:IPD): Why Has This Healthcare Stock Suddenly Grabbed Attention?
Highlights A significant insider share purchase has placed ImpediMed back on the radar of market participants. The medical technology company continues to expand the commercial reach of its bioimpedance spectroscopy platform. Strong insider ownership activity has intensified focus on the company's long-term healthcare growth strategy. ImpediMed is drawing renewed attention following major insider buying activity, healthcare technology innovation and expanding opportunities in patient monitori...
Fiona Bones Bought 911% More Shares In ImpediMed - simplywall.st
Fiona Bones Bought 911% More Shares In ImpediMed simplywall.st
Change of Director's Interest Notice - Ms Fiona Bones
director_dealing announcement
Change of Director's Interest Notice - Mr Andew Grant
director_dealing announcement
Top 20 Quoted Option Holders and Distribution Schedule
other announcement
Notice under Section 708A(5)(e) of the Corporations Act
other announcement
ImpediMed (ASX:IPD) Advances Funding Plans with Successful Share Purchase Plan - Kalkine
ImpediMed (ASX:IPD) Advances Funding Plans with Successful Share Purchase Plan Kalkine
Oversubscribed Share Purchase Plan Successfully Completed
capital_raise announcement

Buy, hold, sell: IPD, Kogan, Rio Tinto shares
Let's take a look at 3 fresh buy, hold, and sell calls from the experts. The post Buy, hold, sell: IPD, Kogan, Rio Tinto shares appeared first on The Motley Fool Australia.
Change of Director's Interest Notice - Ms Janelle Delaney
director_dealing announcement
Change of Director's Interest Notice - Mr Andrew Grant
director_dealing announcement

Why Contact Energy, IPD, Northern Star, and Tower shares are sinking today
In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, … The post Why Contact Energy, IPD, Northern Star, and Tower shares are sinking today appeared first on The Motley Fool Australia.
Why IPD Group Shares Are Falling Despite A Massive 12-Month Rally
Highlights IPD Group shares fell sharply after releasing FY26 earnings guidance. The company still expects strong earnings growth across multiple divisions. Markets may be reacting to elevated expectations following a major share price rally. IPD shares fell despite positive guidance as markets reassessed expectations following a major share price rally. IPD Group Ltd (ASX:IPG) shares moved sharply lower on Thursday despite the company delivering guidance that still points toward strong earni...